These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 29983309

  • 21. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
    Chehal H, Nikitakis NG, Islam MN, Goodchild JH, Mordini L, Bhattacharyya I.
    Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
    [Abstract] [Full Text] [Related]

  • 22. Surgery Combined with LPRF in Denosumab Osteonecrosis of the Jaw: Case Report.
    Maluf G, Pinho MC, Cunha SR, Santos PS, Fregnani ER.
    Braz Dent J; 2016; 27(3):353-8. PubMed ID: 27224573
    [Abstract] [Full Text] [Related]

  • 23. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O, Gerngroß C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, Hahnefeld L, Koerdt S, Otto S, Pautke C.
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [Abstract] [Full Text] [Related]

  • 24. Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice.
    Tamaki S, Kuroshima S, Hayano H, Nakajima K, Kakehashi H, Ishisaki A, Sawase T.
    Bone; 2020 Dec; 141():115560. PubMed ID: 32730924
    [Abstract] [Full Text] [Related]

  • 25. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
    Aoki K, Matsunaga S, Ito S, Shibahara T, Nomura T, Matsuzaki H, Abe S, Yamaguchi A.
    J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of healing time of osteochemonecrosis of the jaw after surgery: Single-center retrospective study and review of the literature].
    Berquet A, Louvrier A, Denis F, Bornert F, Weber E, Meyer C.
    J Stomatol Oral Maxillofac Surg; 2017 Feb; 118(1):11-19. PubMed ID: 28330568
    [Abstract] [Full Text] [Related]

  • 27. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 28. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice.
    Hayano H, Kuroshima S, Sasaki M, Tamaki S, Inoue M, Ishisaki A, Sawase T.
    Bone; 2020 Jun; 135():115308. PubMed ID: 32142911
    [Abstract] [Full Text] [Related]

  • 29. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T.
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Drug-induced osteonecrosis of the jaw: the state of the art.
    Fassio A, Bertoldo F, Idolazzi L, Viapiana O, Rossini M, Gatti D.
    Reumatismo; 2017 May 22; 69(1):9-15. PubMed ID: 28535616
    [Abstract] [Full Text] [Related]

  • 32. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L, Jambura J, Hrusak D, Chalupova M, Posta P, Rusnak S, Vyskocil V.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar 22; 164(1):100-107. PubMed ID: 30647474
    [Abstract] [Full Text] [Related]

  • 33. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, Van den Wyngaert T, Jacobs R.
    Osteoporos Int; 2024 Aug 22; 35(8):1431-1440. PubMed ID: 38767743
    [Abstract] [Full Text] [Related]

  • 34. Successful conservative treatment of jaw osteonecrosis caused by denosumab in patients with multiple bone metastasis.
    Ohga N, Sato J, Asaka T, Morimoto M, Yamazaki Y, Kitagawa Y.
    J Oral Sci; 2018 Aug 22; 60(1):159-162. PubMed ID: 29576576
    [Abstract] [Full Text] [Related]

  • 35. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M.
    Cancer Treat Rev; 2018 Sep 22; 69():177-187. PubMed ID: 30055439
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimicrobial peptide gene expression in medication-related osteonecrosis of the jaw.
    Thiel Y, Ghayor C, Lindhorst D, Essig H, Weber F, Rücker M, Schumann P.
    Pathol Res Pract; 2020 Dec 22; 216(12):153245. PubMed ID: 33065485
    [Abstract] [Full Text] [Related]

  • 38. The Risk of Medication-Related Osteonecrosis of the Jaw in Children: Guidance for Antiresorptive Use in Pediatric Patients.
    Lasky S, Moshal T, Shakoori P, Roohani I, Jolibois M, Youn S, Urata MM, Hammoudeh JA.
    J Oral Maxillofac Surg; 2024 Oct 22; 82(10):1285-1294. PubMed ID: 38950582
    [Abstract] [Full Text] [Related]

  • 39. Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan.
    Nashi M, Kishimoto H, Kobayashi M, Tachibana A, Suematsu M, Fujiwara S, Ota Y, Hashitani S, Shibatsuji T, Nishida T, Fujimura K, Furudoi S, Ishida Y, Ishii S, Fujita T, Iwai S, Shigeta T, Harada T, Miyai D, Takeda D, Akashi M, Noguchi K, Takenobu T.
    J Dent Sci; 2023 Jul 22; 18(3):1156-1163. PubMed ID: 37404599
    [Abstract] [Full Text] [Related]

  • 40. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.
    Hasegawa T, Hayashida S, Kondo E, Takeda Y, Miyamoto H, Kawaoka Y, Ueda N, Iwata E, Nakahara H, Kobayashi M, Soutome S, Yamada SI, Tojyo I, Kojima Y, Umeda M, Fujita S, Kurita H, Shibuya Y, Kirita T, Komori T, Japanese Study Group of Co-operative Dentistry with Medicine (JCDM).
    Osteoporos Int; 2019 Jan 22; 30(1):231-239. PubMed ID: 30406309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.